Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. [JAMA Oncol. 2018]
Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer / Rocco, Bernardo; Eissa, Ahmed; Bianchi, Giampaolo. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 73:4(2018), pp. 639-640. [10.1016/j.eururo.2017.12.004]
Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer
Rocco, Bernardo;Bianchi, Giampaolo
2018
Abstract
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer. [JAMA Oncol. 2018]
| File | Dimensione | Formato | |
|---|---|---|---|
|
senza_titolo.pdf
Accesso riservato
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
149.9 kB
Formato
Adobe PDF
|
149.9 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
